Home / Stocks / RCUS

RCUS insider trading

Arcus Biosciences, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
3
Bought · 24 mo
$15.4M
Buys · last 90 days
0 · $0
Most recent buy
2025-02-27

Cluster buy detected

3 insiders bought RCUS within a short window (2025-02-18→2025-02-27), $15.4M in total — cluster score 75/100. Members see the buyers, the score breakdown and the chart.

See the cluster

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-07-13Jaen Juan C.
President
Sold48,502$30.05$1.5M
2025-12-05Jaen Juan C.
President
Sold82,997$24.71$2.1M
2025-02-27KANEKO YASUNORIcluster
Director
Bought20,000$10.06$201k
2025-02-27ROSEN TERRY Jcluster
Chief Executive Officer
Bought19,800$10.18$202k
2025-02-20GILEAD SCIENCES, INC.cluster
10% owner
Bought1,363,636$11.00$15.0M

Most active insider buyers

InsiderRoleBuysTotal bought
GILEAD SCIENCES, INC.10% owner1$15.0M
ROSEN TERRY JChief Executive Officer1$202k
KANEKO YASUNORIDirector1$201k

See RCUS on the chart

Every insider buy and sell for RCUS plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.